Skip to main content
Clinical Trials/NCT01405469
NCT01405469CompletedNot Applicable

Endoscopic Peroral Myotomy for Treatment of Achalasia: Pilot Study

Universitätsklinikum Hamburg-Eppendorf2 sites in 1 country16 target enrollmentStarted: November 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
16
Locations
2
Primary Endpoint
Treatment Success Defined as Symptom Relief 3 Months After Treatment Based on an Eckhardt Score ≤ 3

Study Overview

Brief Summary

This study intends to investigate the feasibility, safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in a single center setting in Europe.

Detailed Description

This pilot study intends to investigate the feasibility, safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in a single center setting in Europe.

16 patients are enrolled to evaluate feasibility, safety and efficacy of peroral endoscopic myotomy. Main outcome measurement is the eckhardt symptom score 3 month after therapy.

Primary outcome:

-eckhardt symptom score 3 month after therapy.

Secondary outcomes:

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Peroral Endoscopic Myotomy

Experimental

Patients with achalasia who are designed to either get balloon dilatation or have botulinum toxin injection, or to have surgical intervention (Heller myotomy)for treatment

Intervention: Peroral Endoscopic Myotomy (Other)

Outcomes

Primary Outcomes

Treatment Success Defined as Symptom Relief 3 Months After Treatment Based on an Eckhardt Score ≤ 3

Time Frame: 3 months after treatment

eckhardt score is a score to evaluate achalasia discomfort in patients. Patients are being interrogated for dysphagia, regurgitation, and retrosternal pain , correlated with the time frame of occurrence. "with every meal" giving 3 points," daily" (2 points), "sometimes" (1 Point) or "no" (0 Points), as well as weight loss,(\>10 kg= 3 points, 5-10 kg=2 points, 0-5 kg=1 point, None=0 points. Scale range is from 0 Points (no achalasia) up to 12 points for the worst achalasia symptoms.

Secondary Outcomes

  • mmHg of the Lower Esophageal Sphincter 3 Months After POEM Procedure(manometry at 3 month after therapy)
  • Number of Participants With Reflux Symptoms(during procedure, and 3 and 6 months, and 1, 2 and 5 years after treatment)
  • Number of Participants With Procedure-related Adverse Events(procedure to 3 months post procedure)
  • Medication 3 Months After POEM(3 months)
  • Duration Time Procedure(procedure)
  • Days Duration Hospitalization(days of hospitalization for POEM procedure, an average of 4 days)
  • cm Myotomy Length(POEM procedure)
  • Percentage of Participants Who Achieved Treatment Success 3 Months After Treatment(3 months after treatment)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Endoscopic Peroral Myotomy for Treatment... | Clinical Trial